TitleTrajectories of function and biomarkers with age: the CHS All Stars Study.
Publication TypeJournal Article
Year of Publication2016
AuthorsNewman, AB, Sanders, JL, Kizer, JR, Boudreau, RM, Odden, MC, Hazzouri, AZeki Al, Arnold, AM
JournalInt J Epidemiol
Volume45
Issue4
Pagination1135-1145
Date Published2016 Aug
ISSN1464-3685
Abstract
 

BACKGROUND: Multimorbidity is a major driver of physical and cognitive impairment, but rates of decline are also related to ageing. We sought to determine trajectories of decline in a large cohort by disease status, and examined their correspondence with biomarkers of ageing processes including growth hormone, sex steroid, inflammation, visceral adiposity and kidney function pathways.

METHODS: We have followed the 5888 participants in the Cardiovascular Health Study (CHS) for healthy ageing and longevity since 1989-90. Gait speed, grip strength, modified mini-mental status examination (3MSE) and the digit symbol substitution test (DSST) were assessed annually to 1998-99 and again in 2005-06. Insulin-like growth hormone (IGF-1), dehydroepiandrosterone sulphate (DHEAS), interleukin-6 (IL-6), adiponectin and cystatin-C were assessed 3-5 times from stored samples. Health status was updated annually and dichotomized as healthy vs not healthy. Trajectories for each function measure and biomarker were estimated using generalized estimating equations as a function of age and health status using standardized values.

RESULTS: Trajectories of functional decline showed strong age acceleration late in life in healthy older men and women as well as in chronically ill older adults. Adiponectin, IL-6 and cystatin-C tracked with functional decline in all domains; cystatin-C was consistently associated with functional declines independent of other biomarkers. DHEAS was independently associated with grip strength and IL-6 with grip strength and gait speed trajectories.

CONCLUSIONS: Functional decline in late life appears to mark a fundamental ageing process in that it occurred and was accelerated in late life regardless of health status. Cystatin C was most consistently associated with these functional declines.

DOI10.1093/ije/dyw092
Alternate JournalInt J Epidemiol
PubMed ID27272182
Grant ListK01 AG039387 / AG / NIA NIH HHS / United States
R01 AG023629 / AG / NIA NIH HHS / United States